Brief: Cancer Genetics Announces Shareholder Approval
25/03/2021 13:28
March 25 (Reuters) - Cancer Genetics Inc CGIX.O :
* CANCER GENETICS ANNOUNCES SHAREHOLDER APPROVAL OF ALL
PROPOSALS
IN CONNECTION WITH THE PROPOSED MERGER WITH STEMONIX
Source text for Eikon: ID:nGNXZkmyT
Further company coverage: CGIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vyant Bio
See all newsBrief: Vyant Bio Provides Update On Winddown Activities
Brief: Vyant Bio Announces Stockholder Approval Of Plan Of Dissolution
Brief: Vyant Bio Files Form 15 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Filing Of Form 25 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Voluntary Nasdaq Delisting, SEC Deregistration